Articles
Revolutionizing Regenerative Medicine
The Johns Hopkins Translational Tissue Engineering Center (TTEC), a collaborative venture established in 2010 between the Wilmer Eye Institute and Johns Hopkins University's Department of Biomedical Engineering, is revolutionizing regenerative ...
Expanding Accessibility in Neuro-Ophthalmology Care
Faced with a worldwide shortage of neuro-ophthalmologists, Wilmer Eye Institute, Johns Hopkins Medicine, pioneered an approach to ensure that every patient who needs it can be evaluated immediately.
Leading the AI Ophthalmology Revolution
While artificial intelligence suddenly seems to be everywhere, physician-scientists at Wilmer Eye Institute, Johns Hopkins Medicine, have been developing and evaluating AI tools for years.
Deciphering the Complexities of a Rare Disease
Birdshot, as it is familiarly known, is an autoimmune disease that occurs when the body’s immune system mistakenly attacks healthy tissue.
Esen Akpek, M.D., the Bendann Family Professor of Ophthalmology and chief of the Ocular Surface Disease Clinic at Wilmer Eye Institute, is a world-renowned expert in the evaluation and treatment of dry eye disease.
Common Cause, Uncommon Mission
The Wilmer Eye Institute provides untold opportunities for those with shared and overlapping interests to pool their talents, ideas and ideals to advance science and patient care. Following are the stories of two extraordinary clinician-scientists ...
Unlocking the Promise of Nanomaterials
It used to be that if you received a diagnosis of glaucoma, chances were good that you would eventually lose vision to some degree. That began to change with the development of drugs that lower intraocular pressure, elevated levels of which can drive glaucoma.
Game-Changer: How a Simple Quest Led to a Discovery That Promises to Change Lives
Laura Ensign set out to develop a formula to improve the absorption of eye drops, but when she and her team began looking at data on their new formula, they made a stunning discovery.
Home Monitoring of Eye Pressure Comes of Age
A home-based test may ease the burden for the estimated 3 million people in the U.S. with glaucoma, who require regular monitoring of eye pressure.
Implant Offers an Alternative to Eye Drops for Glaucoma Patients
More than half of glaucoma patients don’t adhere to their prescribed treatment plans due to factors that include difficulty in applying eye drops and forgetfulness. A new implant is poised to change that.
New Center Focuses on Genetic Eye Diseases
The Wilmer Genetic Eye Disease Center (GEDi) at Johns Hopkins Medicine offers coordination of care, dedicated genetic counseling and access to all sub-specialties of ophthalmology to patients with genetic eye diseases.
Study Highlights the Need for Workplace Eye Safety Awareness
Open globe injuries occur when the outer membranes of the eye are breached due to trauma. Who is at risk, and what measures can be taken to prevent these often devastating injuries?
Advances in Strabismus Care for Adults and Children
Improving outcomes with Lancaster Red-Green testing and adjustable suture surgery
The Power of Artificial Intelligence
Across Wilmer, scientists are harnessing the promise of “deep learning” to transform research and patient care.
Hopkins researchers chart a course for AI-aided diagnosis of degenerative eye conditions
An interdisciplinary team discovers that machine diagnostics using deep learning can match the performance of human ophthalmologists
The (Remote) Eye Doctor Will See You Now
The ophthalmology telemedicine program is saving patients considerable time and stress.
Artificial Corneas: A Glimmer of Hope Through the Cloud
Sightline Special Edition Annual Report 2014
3-D Modeling: Improving Results of Orbital Surgery
Sightline Special Edition Annual Report 2014
Main: 410-955-5080